Diabetes – Liraglutide

This appraisal specific report is a review of the Mixed Treatment Comparison (MTC) analysis provided by the manufacturer of liraglutide in response to the appraisal consultation document (ACD) (April 2010).

Off

NICE appraisal

TA203 Liraglutide for the treatment of type 2 diabetes (October 2010)

DSU report

Liraglutide for the treatment of type 2 diabetes (PDF, 577KB)

A world top-100 university

We're a world top-100 university renowned for the excellence, impact and distinctiveness of our research-led learning and teaching.